Seres Therapeutics, Inc. - COMMON STOCK (MCRB)

CUSIP: 81750R102

Q1 2021 13F Holders as of 31 Mar 2021

Holder snapshot 7 signals
Share change
+3,663,111
Put/Call ratio
15%
SEC-reported price per share
$20.59
Number of holders
148
Value change
+$72,736,725
Number of buys
84
Open additional details 1 more signal available
Number of sells
62
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
170,403,883

Security key

81750R102

Report period

Q1 2021

Institutions

148

Top holders

10

Ownership snapshot

Top reported holders of MCRB - Seres Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ARK Investment Management...
Disclosed value leader
ARK Investment Management...
Comparable rows
0/15
Latest evidence
31 Dec 2020
13F Highest disclosed value: $336,661,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

ARK Investment Management LLC has the largest disclosed position value at $336.66M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ARK Investment Management LLC's linked filing trail.
Disclosed position value Top 5
ARK Investment Management LLC $336.66M
FMR LLC $277.75M
BlackRock Finance, Inc. $153.71M
Amova Asset Management Americas, ... $142.68M
Sumitomo Mitsui Trust Group, Inc. $142.68M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ARK Investment Management LLC
13F
Company
13F
—
denominator unverified
$336,661,000
13,741,254 shares
— 31 Dec 2020
FMR LLC
13F
Company
13F
—
denominator unverified
$277,746,000
11,336,573 shares
— 31 Dec 2020
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$153,710,000
6,273,836 shares
— 31 Dec 2020
Amova Asset Management Americas, Inc.
13F
Company
13F
—
denominator unverified
$142,678,000
5,823,603 shares
— 31 Dec 2020
Sumitomo Mitsui Trust Group, Inc.
13F
Company
13F
—
denominator unverified
$142,678,000
5,823,603 shares
— 31 Dec 2020
STATE STREET CORP
13F
Company
13F
—
denominator unverified
$88,741,000
3,622,072 shares
— 31 Dec 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
148
Shares
74,799,926
Rows available
148
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2021 vs Q3 2025 Across Filers

Q3 2025 holders
1
Q1 2021 holders
148
Holder diff
147
Investor Q3 2025 Shares Q1 2021 Shares Share Diff Share Chg % Q3 2025 value Q1 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .